Skip to main content
20 minutes minimum delay
Aptinyx Inc. Logo Aptinyx Inc. Logo
  • Our Approach
    • Our Approach
    • NDMA Receptors
    • Therapeutic Area Focus
  • Pipeline
  • Clinical Studies
  • Investors
  • About Us
    • About Aptinyx
    • Leadership Team
    • Board of Directors
    • Working at Aptinyx
    • Contact Us

Site Search

Press Releases

  • Investor Relations
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Analyst Coverage
    • Financials & Filings
      • Quarterly Results
      • Annual Reports & Proxy
      • SEC Filings
    • Governance
      • Governance Documents & Charters
      • Executive Management
      • Board of Directors
      • Committee Composition
    • FAQ & Contacts
      • Investor Contacts
      • Investor FAQs
      • Investor Email Alerts
      • RSS Feeds
Normal
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015
February 27, 2023
Aptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate Update
Download PDF format download (opens in new window)
January 31, 2023
Aptinyx to Present at the SVB Securities Global Biopharma Conference
Download PDF format download (opens in new window)

Quick Links

  • Press Releases
  • Events & Presentations
  • Stock Information

IR Contact

ir@aptinyx.com
847-871-0377

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Aptinyx Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Aptinyx Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

© Aptinyx Inc.   |   Terms of Use   |   Privacy Policy   |  
909 Davis Street, Suite 600, Evanston, IL 60201
Powered By Q4 Inc. 5.91.0.8 (opens in new window)